Benefit of concomitant infrared hyperthermia and low level laser therapy and ionizing
radiation is evaluated in this study. The purpose/objectives: presentation with locally
advanced bulky superficial tumors is clinically challenging. To enhance the efficacy of
chemotherapy and IMRT (intensity-modulated radiation therapy) and/or electron beam
therapy we have developed an inexpensive and clinically effective infrared hyperthermia
approach that combines black-body infrared radiation with halogen spectrum radiation and
discrete wave length infrared clinical lasers LLLT. The goal is to produce a composite
spectrum extending from the far infrared to near infrared and portions of the visible
spectrum with discrete penetrating wavelengths generated by the clinical infrared lasers
with frequencies of 810 nm and/or 830 nm. The composite spectrum from these sources is
applied before and after radiation therapy. We monitor the surface and in some cases
deeper temperatures with thermal probes, but use an array of surface probes as the limiting
safe thermal constraint in patient treatment while at the same time maximizing infrared
entry to deeper tissue layers. Fever-grade infrared hyperthermia is produced in the first
centimeters while non-thermal infrared effects act at deeper tissue layers. The combination
of these effects with ionizing radiation leads to improved tumor control in many cancers.
Access to the requested content is limited to institutions that have purchased or subscribe to SPIE eBooks.
You are receiving this notice because your organization may not have SPIE eBooks access.*
*Shibboleth/Open Athens users─please
sign in
to access your institution's subscriptions.
To obtain this item, you may purchase the complete book in print or electronic format on
SPIE.org.
INSTITUTIONAL Select your institution to access the SPIE Digital Library.
PERSONAL Sign in with your SPIE account to access your personal subscriptions or to use specific features such as save to my library, sign up for alerts, save searches, etc.